deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT03011307

Efficacy of Intrathecal Oxytocin to Speed Recovery After Hip Surgery

Sponsor: Wake Forest University Health Sciences

Conditions Postoperative Pain
Interventions Oxytocin Placebo
Updated 14 times since 2017 Last updated: Nov 1, 2022 Started: Jan 12, 2017 Primary completion: Oct 23, 2020 Completion: Aug 11, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Cessation of funding period prior to completion, due to slow recruitment during the pandemic.

Other terminated trials from Wake Forest University Health Sciences

See all terminations from Wake Forest University Health Sciences

Other Postoperative Pain trials with similar outcome

Browse all Postoperative Pain trials

This PHASE2 trial investigates Postoperative Pain and is currently terminated or withdrawn. Wake Forest University Health Sciences leads this study, which shows 14 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Feb 2017 – ~Dec 2017 · 10 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Sep 2019 · 12 months · monthly snapshot~Sep 2019 – ~Feb 2020 · 5 months · monthly snapshot~Feb 2020 – ~May 2020 · 3 months · monthly snapshot~May 2020 – ~Oct 2020 · 5 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Feb 2022 · 2 months · monthly snapshot~Feb 2022 – ~Dec 2022 · 10 months · monthly snapshot~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Dec 2022 — Jul 2024 [monthly]

    Terminated PHASE2

    Status: Completed → Terminated

  4. Feb 2022 — Dec 2022 [monthly]

    Completed PHASE2

  5. Dec 2021 — Feb 2022 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

▶ Show 9 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Recruiting PHASE2

  2. Oct 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    Status: Active Not Recruiting → Recruiting

  3. May 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  4. Feb 2020 — May 2020 [monthly]

    Recruiting PHASE2

  5. Sep 2019 — Feb 2020 [monthly]

    Recruiting PHASE2

  6. Sep 2018 — Sep 2019 [monthly]

    Recruiting PHASE2

  7. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE2

  8. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  9. Feb 2017 — Dec 2017 [monthly]

    Recruiting PHASE2

    First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Wake Forest University Health Sciences
Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations